


Healthcare Industry NewsFeed
HSMN NewsFeed - 30 Oct 2017
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
HSMN NewsFeed - 26 Oct 2017
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
HSMN NewsFeed - 26 Oct 2017
Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement
Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement
HSMN NewsFeed - 25 Oct 2017
LifeNet Health Provides Uncompromised Fusion Solution with Launch of PliaFX(R) Strip
LifeNet Health Provides Uncompromised Fusion Solution with Launch of PliaFX(R) Strip
HSMN NewsFeed - 25 Oct 2017
Zimmer Biomet Announces U.S. Launch of Vitality(R)+ and Vital(TM) Spinal Fixation Systems
Zimmer Biomet Announces U.S. Launch of Vitality(R)+ and Vital(TM) Spinal Fixation Systems
HSMN NewsFeed - 25 Oct 2017
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
HSMN NewsFeed - 24 Oct 2017
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
HSMN NewsFeed - 24 Oct 2017
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy
HSMN NewsFeed - 24 Oct 2017
Acutus Medical(R) Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
Acutus Medical(R) Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
HSMN NewsFeed - 24 Oct 2017
Stretta Therapy 15-Year Data Shows Long-Term Efficacy of Non-Surgical GERD Treatment
Stretta Therapy 15-Year Data Shows Long-Term Efficacy of Non-Surgical GERD Treatment
HSMN NewsFeed - 24 Oct 2017
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
HSMN NewsFeed - 23 Oct 2017
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
HSMN NewsFeed - 23 Oct 2017
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
HSMN NewsFeed - 20 Oct 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
HSMN NewsFeed - 19 Oct 2017
Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications
Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications
HSMN NewsFeed - 19 Oct 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
HSMN NewsFeed - 19 Oct 2017
Kent Imaging Revolutionizes Perfusion Imaging with their FDA-Cleared KD203
Kent Imaging Revolutionizes Perfusion Imaging with their FDA-Cleared KD203
HSMN NewsFeed - 17 Oct 2017
UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System
UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System
